An international collaborative study by Lawson Health Research Institute, Memorial Sloan Kettering Cancer Center, the Royal Marsden, and Epic Sciences is one of the first to demonstrate that a blood test can predict how patients with advanced prostate cancer will respond to specific treatments, leading to improved survival. The study was published in July 2018… Continue reading Blood Test Can Predict Optimal Treatment for Advanced Prostate Cancer